Related references
Note: Only part of the references are listed.Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
The CEACAM1-mediated apoptosis pathway is activated by CEA and triggers dual cleavage of CEACAM1
S. Nittka et al.
ONCOGENE (2008)
Hypoxia upregulates carcinoembryonic antigen expression in cancer cells
Nina Kokkonen et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Gender differences in non-small cell lung cancer: A population-based study
A. Caldarella et al.
EJSO (2007)
The biology of metastasis to a sanctuary site
Diane Palmieri et al.
CLINICAL CANCER RESEARCH (2007)
Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer
Yoon Kyung Jeon et al.
LUNG CANCER (2006)
CEACAMs: their role in physiology and pathophysiology
Katharina Kuespert et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Her2-targeted therapies in non-small cell lung cancer
Charles Swanton et al.
CLINICAL CANCER RESEARCH (2006)
Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis
H Nakamura et al.
THORAX (2006)
Targeted therapy for the treatment of advanced non-small cell lung cancer - A review of the epidermal growth factor receptor antagonists
GA Silvestri et al.
CHEST (2005)
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic antigen)
RD Blumenthal et al.
CANCER RESEARCH (2005)
Current management of advanced non-small cell lung cancer: Targeted therapy
T Isobe et al.
SEMINARS IN ONCOLOGY (2005)
Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancer
LC Cho et al.
SEMINARS IN ONCOLOGY (2005)
Association of HER-2 overexpression with prognosis in nonsmall cell lung carcinoma: A metaanalysis
H Nakamura et al.
CANCER (2005)
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas - An immunohistomchemical and fluorescence in situ hybridization study
S Suzuki et al.
CANCER (2005)
Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma
M Okada et al.
ANNALS OF THORACIC SURGERY (2004)
Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor
A Iwasaki et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002
AL Visbal et al.
ANNALS OF THORACIC SURGERY (2004)
The blood-brain barrier and its role in immune privilege in the central nervous system
JS Pachter et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer
B Keith et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
AP Meert et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation
C Ilantzis et al.
NEOPLASIA (2002)
Dynamics of brain-derived proteins in cerebrospinal fluid
H Reiber
CLINICA CHIMICA ACTA (2001)
Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma
TJ Robnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
